About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Receipt of R&D Tax Incentive

November 27, 2018

Click here to read more

Post navigation

Phosphagenics Arbitration Award Issued

Voluntary Withdrawal from OTCQX

Related Posts

Expansion of clinical program with the Lambert Initiative

February 22, 2023February 22, 2023

New Agreement with Medterra Pharma

December 20, 2021December 20, 2021

Phosphagenics Announces Results of Dairy Trial

December 22, 2017

Recent Posts

Recruitent recommences for phase III insomnia trial
August 31, 2026
Euroz Hartleys | Successful Phase 3 Interim Results
July 8, 2026
Avecho Phase III insomnia trial advances following positive interim analysis
June 24, 2026

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.